“`html
Practical Solutions and Value of SoftVue Breast Tomographic Ultrasound (BTUS)
This clinical trial article highlights the practical solutions and value of SoftVue BTUS in breast cancer screenings and theranostic treatments.
Key Insights and Vision
- Review provides unique insights into the scientific scope and clinical vision of SoftVue BTUS inventors and pioneers.
- Over 20-year collaboration yielded extensive basic research and technology developments.
- SoftVue received FDA approval as an adjunct to breast cancer screening in women with dense breasts.
Diagnostic Capabilities
- SoftVue confirmed diagnostic goals of tissue characterization and localization of quantitative acoustic tissue differences in 2D and 3D coronal image sequences.
- Characterizes masses within standard cancer risk categories of the Breast Imaging Reporting and Data System.
- Functions as a cost-effective platform for AI-assisted breast cancer identification.
Therapeutic Capabilities
- Facilitates noninvasive temperature monitoring and a unique form of time-reversed, focused US for theranostic treatments.
- Enables localized hyperthermia, drug delivery, and/or ablation.
Patient Preference
- Women prefer the comfort of SoftVue over mammograms.
- Provides less-invasive breast care, from diagnosis to treatment.
“`
